Datamonitor's OTC Pharmaceuticals - Top 5 Emerging Markets Industry Guide is an essential resource for top-level data and analysis covering the OTC Pharmaceuticals industry in each of the Top 5 Emerging markets (Brazil, China, India, Mexico and South Africa). The report includes easily comparable data on market value, volume, segmentation and market share, plus full five year market forecasts. It examines future problems, innovations and potential growth areas within the market.Scope of the Report * Contains an executive summary and data on value, volume and segmentation * Provides textual analysis of the industry's prospects, competitive landscape and profiles of the leading companies* Incorporates in-depth five forces competitive environment analysis and scorecards * Compares data from Brazil, China, India, Mexico and South Africa, alongside individual chapters on each country. . * Includes a five-year forecast of the industryHighlightsThe Top 5 Emerging countries contributed $16.4 billion to the global OTC Pharmaceuticals industry in 2008, with a CAGR of 7.1% between 2004 and 2008In 2013, the market is forecast to have a value of $22.3 billion, with a CAGR of 6.3% over the 2008'2013 period.China is expected to lead the Top 5 emerging nations, with a value of $11.4 billion in 2013.Why you should buy this report * Spot future trends and developments * Inform your business decisions * Add weight to presentations and marketing materials * Save time carrying out entry-level researchMarket DefinitionThe OTC pharmaceuticals market values consists of the total sales of traditional medicines, cough and cold preparations (tablets, mixtures, lozenges, topical remedies, inhalers), vitamins and minerals (multi-vitamins, single minerals, single vitamins, tonics), indigestion preparations (tablets, powders, mixtures), analgesics (Paracetamol, Ibuprofen, Aspirinand other analgesics), and medicated skin products (anti-bacteria's, acne treatments, anti-fungal, disinfectants and other), topical OTC medicines (anesthetic products, anti-itch products, antibiotic creams/gels), plasters & bandages (adhesive bandages/plasters, first aid tape, gauze pads/rolled gauze, liquid bandages and other tape or bandage), first aid kits and other (anti-smoking aids, rectal medications, eye/ear drops, sleeping aids, and motion sickness). Market's values are calculated using retail selling price (RSP) and include any applicable taxes.

1. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
OTC Pharmaceuticals - Top 5 Emerging Markets Industry Guide
Published on March 2010
Report Summary
Datamonitor's OTC Pharmaceuticals - Top 5 Emerging Markets Industry Guide is an essential resource for top-level data and analysis
covering the OTC Pharmaceuticals industry in each of the Top 5 Emerging markets (Brazil, China, India, Mexico and South Africa).
The report includes easily comparable data on market value, volume, segmentation and market share, plus full five year market
forecasts. It examines future problems, innovations and potential growth areas within the market.
Scope of the Report
* Contains an executive summary and data on value, volume and segmentation
* Provides textual analysis of the industry's prospects, competitive landscape and profiles of the leading companies
* Incorporates in-depth five forces competitive environment analysis and scorecards
* Compares data from Brazil, China, India, Mexico and South Africa, alongside individual chapters on each country. .
* Includes a five-year forecast of the industry
Highlights
The Top 5 Emerging countries contributed $16.4 billion to the global OTC Pharmaceuticals industry in 2008, with a CAGR of 7.1%
between 2004 and 2008
In 2013, the market is forecast to have a value of $22.3 billion, with a CAGR of 6.3% over the 2008'2013 period.
China is expected to lead the Top 5 emerging nations, with a value of $11.4 billion in 2013.
Why you should buy this report
* Spot future trends and developments
* Inform your business decisions
* Add weight to presentations and marketing materials
* Save time carrying out entry-level research
Market Definition
The OTC pharmaceuticals market values consists of the total sales of traditional medicines, cough and cold preparations (tablets,
mixtures, lozenges, topical remedies, inhalers), vitamins and minerals (multi-vitamins, single minerals, single vitamins, tonics),
OTC Pharmaceuticals - Top 5 Emerging Markets Industry Guide Page 1/8

2. Find Industry reports, Company profiles
ReportLinker and Market Statistics
indigestion preparations (tablets, powders, mixtures), analgesics (Paracetamol, Ibuprofen, Aspirinand other analgesics), and
medicated skin products (anti-bacteria's, acne treatments, anti-fungal, disinfectants and other), topical OTC medicines (anesthetic
products, anti-itch products, antibiotic creams/gels), plasters & bandages (adhesive bandages/plasters, first aid tape, gauze
pads/rolled gauze, liquid bandages and other tape or bandage), first aid kits and other (anti-smoking aids, rectal medications, eye/ear
drops, sleeping aids, and motion sickness). Market's values are calculated using retail selling price (RSP) and include any applicable
taxes.
Table of Content
TABLE OF CONTENTS
CHAPTER 1 INTRODUCTION 14
1.1 What is this report about' 14
1.2 Who is the target reader' 14
1.3 How to use this report 14
1.4 Definitions 14
CHAPTER 2 TOP 5 EMERGING COUNTRIES OTC PHARMACEUTICALS INDUSTRY OUTLOOK 15
CHAPTER 3 OTC PHARMACEUTICALS IN BRAZIL 19
3.1 Market Overview 19
3.2 Market Value 20
3.3 Market Segmentation I 21
3.4 Market Segmentation II 22
3.5 Market Share 23
3.6 Five Forces Analysis 24
3.7 Leading Companies 33
3.8 Distribution 43
3.9 Market Forecasts 44
3.10 Macroeconomic Indicators 45
CHAPTER 4 OTC PHARMACEUTICALS IN CHINA 47
4.1 Market Overview 47
4.2 Market Value 48
4.3 Market Segmentation I 49
4.4 Market Segmentation II 50
4.5 Market Share 51
4.6 Five Forces Analysis 52
4.7 Leading Companies 61
4.8 Distribution 69
4.9 Market Forecasts 70
4.10 Macroeconomic Indicators 71
CHAPTER 5 OTC PHARMACEUTICALS IN INDIA 73
5.1 Market Overview 73
5.2 Market Value 74
5.3 Market Segmentation I 75
5.4 Market Segmentation II 76
5.5 Market Share 77
5.6 Five Forces Analysis 78
5.7 Leading Companies 86
5.8 Distribution 97
5.9 Market Forecasts 98
OTC Pharmaceuticals - Top 5 Emerging Markets Industry Guide Page 2/8

3. Find Industry reports, Company profiles
ReportLinker and Market Statistics
5.10 Macroeconomic Indicators 99
CHAPTER 6 OTC PHARMACEUTICALS IN MEXICO 101
6.1 Market Overview 101
6.2 Market Value 102
6.3 Market Segmentation I 103
6.4 Market Segmentation II 104
6.5 Market Share 105
6.6 Five Forces Analysis 106
6.7 Leading Companies 114
6.8 Distribution 126
6.9 Market Forecasts 127
6.10 Macroeconomic Indicators 128
CHAPTER 7 OTC PHARMACEUTICALS IN SOUTH AFRICA 130
7.1 Market Overview 130
7.2 Market Value 131
7.3 Market Segmentation 132
7.4 Market Share 133
7.5 Five Forces Analysis 134
7.6 Leading Companies 143
7.7 Distribution 148
7.8 Market Forecasts 149
7.9 Macroeconomic Indicators 151
CHAPTER 8 APPENDIX 153
8.1 Data Research Methodology 153
LIST OF TABLES
Table 1: Top 5 emerging countries OTC Pharmaceuticals industry, revenue ($bn) 2004'13 16
Table 2: Top 5 emerging countries OTC Pharmaceuticals industry, revenue ($bn) 2004'08 17
Table 3: Top 5 emerging countries OTC Pharmaceuticals industry forecast, revenue ($bn) 2008'13 18
Table 4: Brazil OTC Pharmaceuticals Market Value: $ billion, 2004-2008 20
Table 5: Brazil OTC Pharmaceuticals Market Segmentation I: % Share, by Value, 2008 21
Table 6: Brazil OTC Pharmaceuticals Market Segmentation II: % Share, by Value, 2008 22
Table 7: Brazil OTC Pharmaceuticals Market Share: % Share, by Value, 2008 23
Table 8: Key Facts: Johnson & Johnson 33
Table 9: Key Financials: Johnson & Johnson 36
Table 10: Key Facts: Sanofi-Aventis SA 37
Table 11: Key Financials: Sanofi-Aventis SA 38
Table 12: Key Facts: Abbott Laboratories 40
Table 13: Key Financials: Abbott Laboratories 42
Table 14: Brazil OTC Pharmaceuticals Distribution: % Share, by Value, 2008 43
Table 15: Brazil OTC Pharmaceuticals Market Value Forecast: $ billion, 2008-2013 44
Table 16: Brazil Size of Population (million) , 2004-2008 45
Table 17: Brazil GDP (Constant 2000 Prices, $ billion), 2004-2008 45
Table 18: Brazil Inflation, 2004-2008 46
Table 19: Brazil Exchange Rate, 2004-2008 46
Table 20: China OTC Pharmaceuticals Market Value: $ billion, 2004-2008 48
Table 21: China OTC Pharmaceuticals Market Segmentation I: % Share, by Value, 2008 49
Table 22: China OTC Pharmaceuticals Market Segmentation II: % Share, by Value, 2008 50
Table 23: China OTC Pharmaceuticals Market Share: % Share, by Value, 2008 51
Table 24: Key Facts: Johnson & Johnson 61
OTC Pharmaceuticals - Top 5 Emerging Markets Industry Guide Page 3/8

4. Find Industry reports, Company profiles
ReportLinker and Market Statistics
Table 25: Key Financials: Johnson & Johnson 64
Table 26: Key Facts: Novartis AG 65
Table 27: Key Financials: Novartis AG 66
Table 28: Key Facts: Chengdu Rosun Antiseptic Pharmaceutical Co., Ltd 68
Table 29: China OTC Pharmaceuticals Distribution: % Share, by Value, 2008 69
Table 30: China OTC Pharmaceuticals Market Value Forecast: $ billion, 2008-2013 70
Table 31: China Size of Population (million) , 2004-2008 71
Table 32: China GDP (Constant 2000 Prices, $ billion), 2004-2008 71
Table 33: China Inflation, 2004-2008 72
Table 34: China Exchange Rate, 2004-2008 72
Table 35: India OTC Pharmaceuticals Market Value: $ billion, 2004-2008 74
Table 36: India OTC Pharmaceuticals Market Segmentation I: % Share, by Value, 2008 75
Table 37: India OTC Pharmaceuticals Market Segmentation II: % Share, by Value, 2008 76
Table 38: India OTC Pharmaceuticals Market Share: % Share, by Value, 2008 77
Table 39: Key Facts: Cipla Ltd 86
Table 40: Key Financials: Cipla Ltd 88
Table 41: Key Facts: Johnson & Johnson 90
Table 42: Key Financials: Johnson & Johnson 92
Table 43: Key Facts: Piramal Healthcare Limited 94
Table 44: Key Financials: Piramal Healthcare Limited 96
Table 45: India OTC Pharmaceuticals Distribution: % Share, by Value, 2008 97
Table 46: India OTC Pharmaceuticals Market Value Forecast: $ billion, 2008-2013 98
Table 47: India Size of Population (million) , 2004-2008 99
Table 48: India GDP (Constant 2000 Prices, $ billion), 2004-2008 99
Table 49: India Inflation, 2004-2008 100
Table 50: India Exchange Rate, 2004-2008 100
Table 51: Mexico OTC Pharmaceuticals Market Value: $ billion, 2004-2008 102
Table 52: Mexico OTC Pharmaceuticals Market Segmentation I: % Share, by Value, 2008 103
Table 53: Mexico OTC Pharmaceuticals Market Segmentation II: % Share, by Value, 2008 104
Table 54: Mexico OTC Pharmaceuticals Market Share: % Share, by Value, 2008 105
Table 55: Key Facts: Bayer AG 114
Table 56: Key Financials: Bayer AG 117
Table 57: Key Facts: Johnson & Johnson 119
Table 58: Key Financials: Johnson & Johnson 121
Table 59: Key Facts: Boehringer Ingelheim GmbH 123
Table 60: Key Financials: Boehringer Ingelheim GmbH 125
Table 61: Mexico OTC Pharmaceuticals Distribution: % Share, by Value, 2008 126
Table 62: Mexico OTC Pharmaceuticals Market Value Forecast: $ billion, 2008-2013 127
Table 63: Mexico Size of Population (million) , 2004-2008 128
Table 64: Mexico GDP (Constant 2000 Prices, $ billion), 2004-2008 128
Table 65: Mexico Inflation, 2004-2008 129
Table 66: Mexico Exchange Rate, 2004-2008 129
Table 67: South Africa OTC Pharmaceuticals Market Value: $ million, 2004-2008 131
Table 68: South Africa OTC Pharmaceuticals Market Segmentation: % Share, by Value, 2008 132
Table 69: South Africa OTC Pharmaceuticals Market Share: % Share, by Value, 2008 133
Table 70: Key Facts: Weleda Group 143
Table 71: Key Facts: Johnson & Johnson 144
Table 72: Key Financials: Johnson & Johnson 146
Table 73: South Africa OTC Pharmaceuticals Distribution: % Share, by Value, 2008 148
Table 74: South Africa OTC Pharmaceuticals Market Value Forecast: $ million, 2008-2013 149
OTC Pharmaceuticals - Top 5 Emerging Markets Industry Guide Page 4/8

5. Find Industry reports, Company profiles
ReportLinker and Market Statistics
Table 75: South Africa Size of Population (million) , 2004-2008 151
Table 76: South Africa GDP (Constant 2000 Prices, $ billion), 2004-2008 151
Table 77: South Africa Inflation, 2004-2008 152
Table 78: South Africa Exchange Rate, 2004-2008 152
LIST OF FIGURES
Figure 1: Top 5 emerging countries OTC Pharmaceuticals industry, revenue ($bn) 2004'13 15
Figure 2: Top 5 emerging countries OTC Pharmaceuticals industry, revenue ($bn) 2004'08 17
Figure 3: Top 5 emerging countries OTC Pharmaceuticals industry forecast, revenue ($bn) 2008'13 18
Figure 4: Brazil OTC Pharmaceuticals Market Value: $ billion, 2004-2008 20
Figure 5: Brazil OTC Pharmaceuticals Market Segmentation I: % Share, by Value, 2008 21
Figure 6: Brazil OTC Pharmaceuticals Market Segmentation II: % Share, by Value, 2008 22
Figure 7: Brazil OTC Pharmaceuticals Market Share: % Share, by Value, 2008 23
Figure 8: Forces Driving Competition in the OTC Pharmaceuticals Market in Brazil, 2008 24
Figure 9: Drivers of Buyer Power in the OTC Pharmaceuticals Market in Brazil, 2008 26
Figure 10: Drivers of Supplier Power in the OTC Pharmaceuticals Market in Brazil, 2008 27
Figure 11: Factors Influencing the Likelihood of New Entrants in the OTC Pharmaceuticals Market in Brazil, 2008 28
Figure 12: Factors Influencing the Threat of Substitutes in the OTC Pharmaceuticals Market in Brazil, 2008 30
Figure 13: Drivers of Degree of Rivalry in the OTC Pharmaceuticals Market in Brazil, 2008 31
Figure 14: Revenues & Profitability: Johnson & Johnson 36
Figure 15: Revenues & Profitability: Sanofi-Aventis SA 39
Figure 16: Revenues & Profitability: Abbott Laboratories 42
Figure 17: Brazil OTC Pharmaceuticals Distribution: % Share, by Value, 2008 43
Figure 18: Brazil OTC Pharmaceuticals Market Value Forecast: $ billion, 2008-2013 44
Figure 19: China OTC Pharmaceuticals Market Value: $ billion, 2004-2008 48
Figure 20: China OTC Pharmaceuticals Market Segmentation I: % Share, by Value, 2008 49
Figure 21: China OTC Pharmaceuticals Market Segmentation II: % Share, by Value, 2008 50
Figure 22: China OTC Pharmaceuticals Market Share: % Share, by Value, 2008 51
Figure 23: Forces Driving Competition in the OTC Pharmaceuticals Market in China, 2008 52
Figure 24: Drivers of Buyer Power in the OTC Pharmaceuticals Market in China, 2008 54
Figure 25: Drivers of Supplier Power in the OTC Pharmaceuticals Market in China, 2008 55
Figure 26: Factors Influencing the Likelihood of New Entrants in the OTC Pharmaceuticals Market in China, 2008 56
Figure 27: Factors Influencing the Threat of Substitutes in the OTC Pharmaceuticals Market in China, 2008 58
Figure 28: Drivers of Degree of Rivalry in the OTC Pharmaceuticals Market in China, 2008 59
Figure 29: Revenues & Profitability: Johnson & Johnson 64
Figure 30: Revenues & Profitability: Novartis AG 67
Figure 31: China OTC Pharmaceuticals Distribution: % Share, by Value, 2008 69
Figure 32: China OTC Pharmaceuticals Market Value Forecast: $ billion, 2008-2013 70
Figure 33: India OTC Pharmaceuticals Market Value: $ billion, 2004-2008 74
Figure 34: India OTC Pharmaceuticals Market Segmentation I: % Share, by Value, 2008 75
Figure 35: India OTC Pharmaceuticals Market Segmentation II: % Share, by Value, 2008 76
Figure 36: India OTC Pharmaceuticals Market Share: % Share, by Value, 2008 77
Figure 37: Forces Driving Competition in the OTC Pharmaceuticals Market in India, 2008 78
Figure 38: Drivers of Buyer Power in the OTC Pharmaceuticals Market in India, 2008 80
Figure 39: Drivers of Supplier Power in the OTC Pharmaceuticals Market in India, 2008 81
Figure 40: Factors Influencing the Likelihood of New Entrants in the OTC Pharmaceuticals Market in India, 2008 82
Figure 41: Factors Influencing the Threat of Substitutes in the OTC Pharmaceuticals Market in India, 2008 84
Figure 42: Drivers of Degree of Rivalry in the OTC Pharmaceuticals Market in India, 2008 85
Figure 43: Revenues & Profitability: Cipla Ltd 89
OTC Pharmaceuticals - Top 5 Emerging Markets Industry Guide Page 5/8

6. Find Industry reports, Company profiles
ReportLinker and Market Statistics
Figure 44: Revenues & Profitability: Johnson & Johnson 93
Figure 45: Revenues & Profitability: Piramal Healthcare Limited 96
Figure 46: India OTC Pharmaceuticals Distribution: % Share, by Value, 2008 97
Figure 47: India OTC Pharmaceuticals Market Value Forecast: $ billion, 2008-2013 98
Figure 48: Mexico OTC Pharmaceuticals Market Value: $ billion, 2004-2008 102
Figure 49: Mexico OTC Pharmaceuticals Market Segmentation I: % Share, by Value, 2008 103
Figure 50: Mexico OTC Pharmaceuticals Market Segmentation II: % Share, by Value, 2008 104
Figure 51: Mexico OTC Pharmaceuticals Market Share: % Share, by Value, 2008 105
Figure 52: Forces Driving Competition in the OTC Pharmaceuticals Market in Mexico, 2008 106
Figure 53: Drivers of Buyer Power in the OTC Pharmaceuticals Market in Mexico, 2008 108
Figure 54: Drivers of Supplier Power in the OTC Pharmaceuticals Market in Mexico, 2008 109
Figure 55: Factors Influencing the Likelihood of New Entrants in the OTC Pharmaceuticals Market in Mexico, 2008 110
Figure 56: Factors Influencing the Threat of Substitutes in the OTC Pharmaceuticals Market in Mexico, 2008 112
Figure 57: Drivers of Degree of Rivalry in the OTC Pharmaceuticals Market in Mexico, 2008 113
Figure 58: Revenues & Profitability: Bayer AG 118
Figure 59: Revenues & Profitability: Johnson & Johnson 122
Figure 60: Revenues & Profitability: Boehringer Ingelheim GmbH 125
Figure 61: Mexico OTC Pharmaceuticals Distribution: % Share, by Value, 2008 126
Figure 62: Mexico OTC Pharmaceuticals Market Value Forecast: $ billion, 2008-2013 127
Figure 63: South Africa OTC Pharmaceuticals Market Value: $ million, 2004-2008 131
Figure 64: South Africa OTC Pharmaceuticals Market Segmentation: % Share, by Value, 2008 132
Figure 65: South Africa OTC Pharmaceuticals Market Share: % Share, by Value, 2008 133
Figure 66: Forces Driving Competition in the OTC Pharmaceuticals Market in South Africa, 2008 134
Figure 67: Drivers of Buyer Power in the OTC Pharmaceuticals Market in South Africa, 2008 136
Figure 68: Drivers of Supplier Power in the OTC Pharmaceuticals Market in South Africa, 2008 137
Figure 69: Factors Influencing the Likelihood of New Entrants in the OTC Pharmaceuticals Market in South Africa, 2008 138
Figure 70: Factors Influencing the Threat of Substitutes in the OTC Pharmaceuticals Market in South Africa, 2008 140
Figure 71: Drivers of Degree of Rivalry in the OTC Pharmaceuticals Market in South Africa, 2008 141
Figure 72: Revenues & Profitability: Johnson & Johnson 147
Figure 73: South Africa OTC Pharmaceuticals Distribution: % Share, by Value, 2008 148
Figure 74: South Africa OTC Pharmaceuticals Market Value Forecast: $ million, 2008-2013 150
OTC Pharmaceuticals - Top 5 Emerging Markets Industry Guide Page 6/8

7. Find Industry reports, Company profiles
ReportLinker and Market Statistics
Fax Order Form
To place an order via fax simply print this form, fill in the information below and fax the completed form to:
Europe, Middle East and Africa : + 33 4 37 37 15 56
Asia, Oceania and America : + 1 (805) 617 17 93
If you have any questions please visit http://www.reportlinker.com/notify/contact
Order Information
Please verify that the product information is correct and select the format(s) you require.
OTC Pharmaceuticals - Top 5 Emerging Markets Industry Guide
Product Formats
Please select the product formats and the quantity you require.
Digital Copy--USD 995.00 Quantity: _____
Contact Information
Please enter all the information below in BLOCK CAPITALS
Title: Mr Mrs Dr Miss Ms Prof
First Name: _____________________________ Last Name: __________________________________
Email Address: __________________________________________________________________________
Job Title: __________________________________________________________________________
Organization: __________________________________________________________________________
Address: __________________________________________________________________________
City: __________________________________________________________________________
Postal / Zip Code: __________________________________________________________________________
Country: __________________________________________________________________________
Phone Number: __________________________________________________________________________
Fax Number: __________________________________________________________________________
OTC Pharmaceuticals - Top 5 Emerging Markets Industry Guide Page 7/8

8. Find Industry reports, Company profiles
ReportLinker and Market Statistics
Payment Information
Please indicate the payment method, you would like to use by selecting the appropriate box.
Payment by credit card Card Number: ______________________________________________
Expiry Date __________ / _________
CVV Number _____________________
Card Type (ex: Visa, Amex…) _________________________________
Payment by wire transfer Crédit Mutuel
RIB : 10278 07314 00020257701 89
BIC : CMCIFR2A
IBAN : FR76 1027 8073 1400 0202 5770 189
Payment by check UBIQUICK SAS
16 rue Grenette – 69002 LYON, FRANCE
Customer signature:
Please note that by ordering from Reportlinker you are agreeing to our Terms and Conditions at
http://www.reportlinker.com/index/terms
Please fax this form to:
Europe, Middle East and Africa : + 33 4 37 37 15 56
Asia, Oceania and America : + 1 (805) 617 17 93
OTC Pharmaceuticals - Top 5 Emerging Markets Industry Guide Page 8/8